Dame Carol Robinson

Dame Carol Robinson

Oprichter bij OMass Therapeutics Ltd.

Commercial Services

Oorsprong van het eerstegraads netwerk van Dame Carol Robinson

EntiteitType entiteitIndustrie
11
Holding Company Miscellaneous Commercial Services 11

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Dame Carol Robinson via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
JUNIPER PHARMACEUTICALS INC Pharmaceuticals: Major

James Geraghty

Chairman

JOHNSON & JOHNSON Pharmaceuticals: Major

Jonathan Montagu

Corporate Officer/Principal

Medical Specialties

James Geraghty

Corporate Officer/Principal

CONCERT PHARMACEUTICALS, INC. Pharmaceuticals: Major

Jonathan Montagu

Corporate Officer/Principal

Biotechnology

Jonathan Montagu

Nathalie Franchimont

Chief Operating Officer

Chief Tech/Sci/R&D Officer

Stanford University College/University

Jonathan Montagu

Magdalena Jonikas

Masters Business Admin

Doctorate Degree

University of Pennsylvania College/University

James Geraghty

Magdalena Jonikas

Graduate Degree

Undergraduate Degree

University of Oxford College/University

Edward Hodgkin

Jonathan Montagu

Doctorate Degree

Graduate Degree

The University of Manchester College/University

Christopher Ashton

Doctorate Degree

BLUEBIRD BIO, INC. Biotechnology

James Geraghty

Director/Board Member

University of Cambridge College/University

Rosamond Deegan

Graduate Degree

Investment Managers

Jonathan Montagu

Consultant / Advisor

INSEAD College/University

Rosamond Deegan

Masters Business Admin

Georgetown University College/University

James Geraghty

Undergraduate Degree

Bio Ventures for Global Health

James Geraghty

Director/Board Member

GlaxoSmithKline (Pharmaceutical Operations)

Jonathan Montagu

Corporate Officer/Principal

Pharmaceuticals: Major

James Geraghty

Director/Board Member

Pharmaceuticals: Major

James Geraghty

Director/Board Member

TREVENA, INC. Pharmaceuticals: Major

Rosamond Deegan

Chief Operating Officer

Miscellaneous Commercial Services

Edward Hodgkin

Chairman

Pharmaceuticals: Major

James Geraghty

President

Miscellaneous Commercial Services

Jonathan Montagu

Corporate Officer/Principal

Pharmaceuticals: Major

Christopher Ashton

Chief Executive Officer

Investment Managers

Christopher Ashton

Edward Hodgkin

Magdalena Jonikas

Private Equity Investor

Private Equity Investor

Private Equity Investor

Yale Law School College/University

James Geraghty

Graduate Degree

VOYAGER THERAPEUTICS, INC. Biotechnology

James Geraghty

Director/Board Member

PIERIS PHARMACEUTICALS, INC. Biotechnology

James Geraghty

Chairman

Investment Managers

Christopher Ashton

Consultant / Advisor

Biotechnology

Edward Hodgkin

Chief Executive Officer

Biotechnology

James Geraghty

Chairman

FULCRUM THERAPEUTICS, INC. Pharmaceuticals: Major

James Geraghty

Director/Board Member

Electronics Distributors

Jonathan Montagu

Chief Executive Officer

Miscellaneous Commercial Services

Lachlan Mackinnon

Director/Board Member

Miscellaneous Commercial Services

Lachlan Mackinnon

Director/Board Member

AUTOLUS THERAPEUTICS PLC Biotechnology

Edward Hodgkin

Director/Board Member

Biotechnology

Jonathan Montagu

Founder

Pharmaceuticals: Major

Magdalena Jonikas

Director/Board Member

Biotechnology

Christopher Ashton

Chairman

Miscellaneous Commercial Services

Edward Hodgkin

Director/Board Member

PEPGEN INC. Biotechnology

Christopher Ashton

Director/Board Member

ACHILLES THERAPEUTICS PLC Pharmaceuticals: Major

Christopher Ashton

Chief Executive Officer

Investment Managers

James Geraghty

Corporate Officer/Principal

Statistieken

Internationaal

Verenigde Staten 28
Verenigd Koninkrijk 17
Frankrijk 4
Israël 2
Nederland 2

Sectoraal

Health Technology 28
Consumer Services 9
Commercial Services 6
Finance 5
Technology Services 2

Operationeel

Director/Board Member 28
Corporate Officer/Principal 14
Chairman 12
Chief Executive Officer 10
Independent Dir/Board Member 9
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU